Blue Sky MD Review: What the $40 and $60 Weekly GLP-1 Prices Leave to Budget

A weekly medication price can make a weight-loss program look easy to budget. Blue Sky MD’s advertised starting points—$40 for semaglutide and $60 for tirzepatide—are more specific than a promise of “affordable care,” but they answer only part of the financial question. Both offers concern in-office treatment for qualified patients, and enrollment in the practice’s medical weight-loss program is required. The available pages do not establish what a patient pays to start, what subsequent bills total or which formulation corresponds to either advertised price.

This documentary review examines Blue Sky MD as a North Carolina medical practice, not as a medication-only subscription. Its documented model combines clinical assessment, laboratory testing, coaching, follow-up and potential prescribing, with seven clinics and statewide telehealth. Sources were consulted October 19, 2026; that is not necessarily when the pages were updated. The central cost question is whether the practice can turn its separate service and medication descriptions into a written, patient-specific estimate before enrollment—not whether the lowest weekly figure looks competitive in isolation.

At a glance

Advertised medication starting prices: Qualified, enrolled patients are offered in-office self-pay semaglutide starting at $40 per week or tirzepatide starting at $60 per week; the exact formulation behind either price is not identified.
Sources: [7]
Separate program expenses: The Charlotte page says office visits and laboratory work are usually billed to insurance; it does not present the weekly medication figures as a guaranteed total program price.
Sources: [11]
Enrollment requirement: Blue Sky MD says it does not prescribe weight-loss medication to patients outside its medical weight-loss program.
Sources: [5]
Documented medication choices: The Charlotte page lists Wegovy, Ozempic and compounded semaglutide options, plus Zepbound and Mounjaro tirzepatide, within a full medical weight-loss plan.
Sources: [11]
Service territory: The practice lists seven North Carolina clinics and statewide telehealth, with some blood draws and medically necessary appointments remaining in person.
Sources: [5] [6]

Start with the weekly price, but do not mistake it for the bill

Blue Sky MD’s self-pay offer is explicitly conditional: semaglutide starts as low as $40 per week, in office, and tirzepatide starts as low as $60 per week, in office. Patients must medically qualify and belong to the weight-loss program. The practice also advertises brand-name options, but the supplied pages do not connect a particular brand, compounded formulation, dose or presentation to either starting price. It would therefore be misleading to label these as confirmed Wegovy, Ozempic, Zepbound or Mounjaro prices.

The Charlotte page supplies the most important qualification: office visits and labs are usually billed to insurance like primary-care visits. That establishes a distinction between the weekly medication offer and other care charges, not a promise that insurance pays those charges in full. The broader program page says out-of-pocket costs vary with insurance billing and patient goals. A useful estimate needs separate lines for medication, visits, laboratory testing and any enrollment or maintenance charges that apply.

The evidence does not identify the collection schedule behind “per week.” It does not say whether patients pay weekly, receive a periodic invoice or pay another amount upfront. Nor does it establish a calendar-month package, four-week supply or introductory discount followed by a higher rate. Our guide to GLP-1 billing intervals explains why the advertised unit and the actual billing cycle should be confirmed separately. Here, the weekly figure is a starting-price unit, not a complete payment schedule.

What Blue Sky MD documents—and what belongs in a written estimate
Cost component	Documented position	Question to settle
Semaglutide	Starts at $40 per week, in office, for qualified enrolled patients	Which formulation and presentation does this price purchase?
Tirzepatide	Starts at $60 per week, in office, for qualified enrolled patients	Which product is supplied, and when can the price change?
Visits and laboratory work	Charlotte says these are usually billed to insurance	What are the expected patient charges under my plan?
Virtual visits	Online-care page says they are included without an additional charge	Does that apply to my specific program and appointment type?
Ongoing care	Follow-up, repeat labs and maintenance are described	Which services are included, and which generate separate bills?

Sources: [7] [11] [9]

The free assessment is not a documented free medical workup

Blue Sky MD describes its first step as a short, free health assessment covering goals, history and previous weight-loss efforts, intended to match the patient with a care team. Separately, it describes a medical consultation reviewing BMI and medical history, followed by a plan that may include GLP-1 medication if appropriate. Those are distinct descriptions. The free assessment should not be read as proof that the prescribing consultation, baseline testing or every service before medication approval carries no charge. Blue Sky MD says its services may be inappropriate for people who are pregnant, breastfeeding or under 18, and for those with unstable medical conditions, active substance-use issues, untreated eating disorders or certain psychiatric conditions affecting treatment compliance and safety. It also warns that GLP-1 medicines are not suitable for everyone and may cause gastrointestinal side effects and serious complications; suitability requires individual clinical review.

The program advertises a panel of more than 20 biomarkers and direct measurement of resting metabolism before treatment recommendations. Listed areas include insulin, glucose, thyroid function and sex hormones. Charlotte describes a full hormone and metabolic panel plus resting metabolic-rate testing, with results arriving within two business days. That is a laboratory-results statement—not a medication approval, prescription dispatch or treatment-start deadline. The pages do not itemize the patient price of each initial test or explain how coverage is determined.

Before completing paid services, request the amount due at the first medical appointment and the expected laboratory responsibility, including what happens financially if medication is not prescribed. Blue Sky MD says it helps verify benefits before patients commit, which provides a practical opening for that discussion. The distinction between a free entry point and chargeable clinical care is also addressed in our guide to the first GLP-1 payment. The supplied evidence does not establish a refund entitlement after an assessment or evaluation.

Sources: [9] [5] [11]

Insurance acceptance does not settle medication coverage

The practice says it is in network with most major primary-care plans and lists Medicaid, Blue Cross and Medicare among accepted insurance types. Those are provider statements, not verification of an individual network relationship or benefit. Its program description says many visits, labs and treatments may be billed through insurance depending on the plan. More specifically, its GLP-1 article distinguishes coverage for parts of medical weight management from coverage for the medication itself, which depends on the patient’s plan.

One online-care page makes the much broader statement that telehealth is covered by all insurance carriers. That wording is not consistent in scope with the plan-dependent qualifications elsewhere. The financially cautious reading is not to assume universal payment: ask the practice and insurer about the specific visit, clinician, location and service. A covered appointment can still leave patient responsibility, and accepting an insurance type does not establish that a particular GLP-1 prescription will be covered.

Blue Sky MD also advertises self-pay options as HSA/FSA-eligible. That is a commercial description rather than an individualized tax or account-eligibility determination. Ask for documentation suitable for your account administrator and a side-by-side explanation of the relevant insurance and self-pay charges. Our guide to insurance and self-pay questions offers a framework for separating these decisions. The reviewed material does not establish special government-insurance exclusions or a universal self-pay price for every service.

Sources: [9] [7] [6]

Program enrollment buys a care relationship, not just prescribing access

Blue Sky MD expressly declines standalone weight-loss prescribing outside its program. It describes weekly in-person meetings with a wellness coach, checkups with a medical provider, access to its mobile app and medication prescribing when deemed appropriate. The practice says Dr. David LaMond founded it, identifies him as medical director and names registered dietitian Kristen Hunter as program director. Its stated team includes physicians, nurse practitioners, dietitians and wellness coaches; this does not mean every appointment is with a physician.

The app is described as a direct communication channel to wellness coaches between visits, with food journaling, recipes and activity tracking. Another page says patients can track weight changes and schedule virtual coaching sessions through it. These are concrete support features, but the evidence does not provide guaranteed response times or establish that app messages receive clinician review. Ask which questions belong with a coach, which require a medical appointment and whether an additional visit produces another charge.

Duration is individualized according to goals and patient commitment, with the practice recommending continuation until goal weight and longer if support is desired. It also describes repeat laboratory testing, plan adjustments and a maintenance phase. That recommendation is not a documented minimum contract term. From a cost perspective, the unresolved issue is how charges evolve across those phases: the pages explain the care activities more clearly than their frequency, bundled status or maintenance pricing.

Sources: [9] [5]

In-office pricing and telehealth access need to be reconciled

The seven listed clinics are North Charlotte, South Charlotte, Mooresville, Greensboro, Winston-Salem/Clemmons, Asheville and Hendersonville. Blue Sky MD also advertises statewide North Carolina telehealth. Its published clinic hours are Monday through Thursday, 7:30 a.m. to 4:30 p.m., and Friday, 7:30 a.m. to 1 p.m. Those hours can matter when assessing the practical cost of attending appointments. The evidence does not confirm telehealth treatment for patients located outside North Carolina.

The online-care page says virtual visits are included in the program without additional cost and are no different from in-person visits. It nevertheless preserves in-person exceptions for blood draws and medically necessary appointments. Meanwhile, the general GLP-1 page allows an initial in-person or telehealth consultation, but Charlotte describes a first in-person visit for baseline labs before most follow-ups move online. These descriptions leave room for different local workflows rather than establishing one universal fully remote pathway.

Because the advertised medication prices specifically say “in-office,” a prospective telehealth patient should ask whether those figures apply to their arrangement. The supplied pages do not settle that question. For virtual booking assistance, the practice lists calling (828) 651-0450 or texting (844) 755-1380. Use that contact to confirm the first appointment location, testing arrangements, expected visit cadence and whether any medication is collected in person or sent to an address.

Sources: [5] [7] [6] [11]

Product identity and pharmacy responsibility remain important gaps

Charlotte explicitly lists branded and compounded semaglutide options, alongside Zepbound and Mounjaro tirzepatide. The program article describes semaglutide and tirzepatide as weekly injections; the supplied evidence does not document an oral offer. A general FAQ also refers to “the medication we compound ourselves.” That wording leaves the preparing entity unclear. It does not identify a dispensing pharmacy, establish the exact ingredients or explain which preparation corresponds to an advertised starting price.

These gaps matter beyond comparison shopping. FDA states that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality; nonapproval alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Approval attaches to a specific product, not to Blue Sky MD or a pharmacy. A quote should therefore identify the actual product and responsible pharmacy.

Blue Sky MD says that after medication approval, the prescription will be ordered and sent to the preferred address within three to five business days. That wording does not establish a separate arrival deadline. Shipping fees, carrier, tracking, refrigeration arrangements and replacement terms are not documented in the supplied material. FDA advises not using an injectable GLP-1 product that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. The financial question is who handles and pays for resolving an affected shipment.

Sources: [11] [7] [5] [1]

Ongoing care is documented; renewal and exit terms are not

The reviewed pages do not establish automatic renewal, a minimum commitment, prepayment requirements, cancellation deadlines or refund rules. They also do not document introductory pricing followed by a specified renewal amount. Missing terms are not evidence that enrollment is commitment-free or that payments are refundable. Before authorizing payment, request the applicable agreement and ask what ends when enrollment ends: coaching access, scheduled appointments, prescribing services and any pending medication order may involve different responsibilities.

The practice requires an initial medical consultation, ongoing monitoring and regular follow-up. That clinical structure should be distinguished from a billing arrangement: needing follow-up does not by itself reveal how often payments occur or whether every follow-up is included. NIDDK explains that medication selection involves benefits, side effects, health conditions, other medicines and costs, and that treatment duration depends on response and side effects. Continued care therefore cannot be evaluated solely as a succession of medication purchases.

For this practice, an actionable budget should show the first payment, the expected next payment, separately billed services and the maintenance-stage estimate, together with the cancellation and refund language. Our written-quote checklist can help organize that request. Do not treat the recommendation to remain until goal weight as proof of a contractual obligation, or assume that canceling future services reverses charges for care or medication already ordered. Neither conclusion is established by the reviewed evidence.

Sources: [5] [9] [2]

Keep adjacent services and performance claims out of the base-price assumption

Blue Sky MD is broader than a GLP-1 prescribing service. Charlotte advertises women’s hormone therapy using options described as bioidentical, including pellets, transdermal and oral presentations with follow-up testing. Both Charlotte clinics also advertise testosterone replacement therapy for men, beginning with hormone and metabolic testing, an in-person review and subsequent monitoring. These offerings describe separate areas of the business; their presence does not establish that hormone treatment is necessary for, or included in, a weight-loss program.

The practice also identifies DermaBlue as a sister practice for referrals concerning skin changes and lost volume. Those aesthetic services are not presented as included weight-management benefits. Likewise, Blue Sky MD’s self-reported LegitScript certification is a provider claim, not independent verification performed for this review. None of these adjacent offerings or credentials resolves the missing total price. A comparison should stay anchored to the services actually quoted for the patient rather than the breadth of the practice’s marketing.

Finally, Blue Sky MD expressly says it cannot guarantee specific treatment results. Published medication trials do not establish outcomes for this practice, its compounded preparations or an individual patient. A higher program charge would not, by itself, demonstrate better clinical results; a lower starting medication price would not establish equivalent service scope. The strongest documented financial distinction is the combination of clinic-based access and ongoing support, while the weakest is the absence of a complete public price and payment schedule.

Sources: [8] [11] [10] [5] [3] [4]

Questions & answers

Is Blue Sky MD’s $40 semaglutide price the full program cost?

No full-program total is established. The offer starts at $40 per week for in-office semaglutide for qualified patients enrolled in the medical weight-loss program. Charlotte says visits and labs are usually billed to insurance separately. The exact formulation behind the offer is not identified, so it should not be treated as a confirmed branded-product price.

Sources: [7] [11]

Can I get only a prescription from Blue Sky MD?

The practice says no: it does not prescribe weight-loss medication to patients outside its medical weight-loss program. Enrollment involves a broader care model with coaching, medical follow-up and app access. Prescribing remains conditional on clinical assessment; paying for or joining the program is not a documented guarantee that a GLP-1 prescription will be issued.

Sources: [5] [9]

Does accepting Medicare or Medicaid mean my medication is covered?

No individual medication benefit follows from the practice listing Medicare or Medicaid among accepted insurance types. Blue Sky MD separately says GLP-1 drug coverage depends on the plan. Ask for confirmation of both the practice services and the exact prescription. Its offer to help verify benefits is useful, but it is not itself a coverage guarantee.

Sources: [9] [7]

Can my first Blue Sky MD appointment be virtual?

The general GLP-1 page allows an initial consultation in person or by telehealth, while Charlotte describes a first in-person visit for baseline labs before most follow-ups become virtual. The online-care page also preserves in-person blood draws and necessary medical appointments. Confirm the workflow for your chosen clinic rather than assuming the whole program can be completed remotely.

Sources: [5] [11] [6]

Which pharmacy prepares or dispenses Blue Sky MD’s medication?

The supplied pages do not identify the responsible pharmacy. Charlotte documents compounded semaglutide options, and another FAQ refers to medication the practice compounds itself, without resolving the preparing entity or formulation. Ask for the dispensing pharmacy, preparation details and product label before purchase. Do not assume the advertised weekly price identifies the same product across all treatment pathways.

Sources: [11] [5] [7]

Is the three-to-five-business-day statement a delivery guarantee?

No separate arrival guarantee is documented. Blue Sky MD says that after medication approval, the prescription will be ordered and sent to the preferred address within three to five business days. Ask about actual transit expectations, shipping charges, refrigeration and replacement responsibility. FDA advises not using an injectable GLP-1 that arrives warm or inadequately refrigerated and contacting the provider or pharmacy.

Sources: [5] [1]

Our assessment

Blue Sky MD documents a substantive North Carolina weight-management service: clinic access, potential telehealth follow-up, metabolic testing, coaching, app tools and multiple medication options. Its weekly self-pay starting prices are useful disclosures, but they are not sufficient for an all-in cost comparison. The decisive next step is a written estimate identifying the exact medication, initial medical and laboratory charges, billing interval, ongoing services, maintenance costs and exit terms. Insurance verification should distinguish practice services from drug benefits. Pharmacy identity and the relationship between in-office prices and shipped medication also need clarification. For someone considering this care model, the record supports further questions—not a conclusion that the lowest advertised weekly amount represents the final budget.

Visit Blue Sky MD’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Blue Sky MD Review: What the $40 and $60 Weekly GLP-1 Prices Leave to Budget

At a glance

01Start with the weekly price, but do not mistake it for the bill

02The free assessment is not a documented free medical workup

03Insurance acceptance does not settle medication coverage

04Program enrollment buys a care relationship, not just prescribing access

05In-office pricing and telehealth access need to be reconciled

06Product identity and pharmacy responsibility remain important gaps

07Ongoing care is documented; renewal and exit terms are not

08Keep adjacent services and performance claims out of the base-price assumption